Infections and outcomes after cardiac surgery-The impact of outbreaks traced to transesophageal echocardiography probes. by Vesteinsdottir, Edda et al.
Acta Anaesthesiol Scand. 2019;63:871–878. wileyonlinelibrary.com/journal/aas | 871
1  | INTRODUC TION
Infections are among the most frequent complications after cardiac 
surgery1,2 and have consistently been linked to longer duration of 
stay and increased mortality.3-5 Recent reports have shown rates 
of surgical site infections from 4.9% to 8.1%,6,7 urinary tract in-
fections from 0.7% to 6%,6,8-10 blood stream infections from 1.1% 
to 2.3%,3,8,10,11 and deep sternal wound infections from 0.6% to 
1.6%.3,9,10
Post-operative pneumonia, in particular, has been the subject of 
numerous studies, reporting variable incidence rates, from 2.4% to 
10.7%.3,6,9,13,14 Many risk factors for developing pneumonia post-op-
eratively have been identified and include: age,9,13,14,18 chronic pul-
monary disease,3,9,13,14 heart failure,3,9 female gender,5,9,19 duration 
of surgery3 and cardiopulmonary bypass,14 duration of mechanical 
ventilation,3,13,18,19 re-intubation,17,18,20 transfusion of blood prod-
ucts14,17,18 and emergency surgery.4 Most of these factors are not 
amenable to modification.
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Background: Infections are a frequent complication of cardiac surgery. The intraop-
erative use of transesophageal echocardiography (TEE) may be an underrecognized 
risk factor for post-operative infections. The aim of this study was to investigate in-
fection rates and outcomes after cardiac surgery in a nationwide cohort, especially in 
relation to periods where surface damaged TEE probes were used.
Methods: This was a retrospective, observational study at Landspitali University 
Hospital. All consecutive cardiac surgery patients from 1 January 2013 to 31
December 2017 were included. Patients’ charts were reviewed for evidence of infec-
tion, post-operative complications or death.
Results: During the study period, 973 patients underwent cardiac surgery at Landspitali 
and 198 (20.3%) developed a post-operative infection. The most common infections 
were: Pneumonia (9.1%), superficial surgical site (5.7%), bloodstream (2.8%) and deep 
sternal wound (1.7%). Risk factors for developing an infection included: The duration of 
procedure, age, insulin-dependent diabetes, EuroScore II, reoperation for bleeding and 
an operation in a period with a surface damaged TEE probe in use. Twenty-two patients 
were infected with a multidrug resistant strain of Klebsiella oxytoca, 10 patients with 
Pseudomonas aeruginosa and two patients developed endocarditis with Enterococcus 
faecalis.AllthreepathogenswereculturedfromtheTEEprobeinuseatrespectivetime,
after decontamination. The 30-day mortality rate in the patient cohort was 3.2%.
Conclusions: The intraoperative use of surface damaged TEE probes caused two se-
rious infection outbreaks in patients after cardiac surgery. TEE probes need careful 
visual inspection during decontamination and probe sheaths are recommended.
ThisisanopenaccessarticleunderthetermsoftheCreativeCommonsAttribution-NonCommercial-NoDerivsLicense,whichpermitsuseanddistributionin
any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
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Alesswell-knownpotentialcausativefactorinthedevelopment
of pneumonia after cardiac surgery is the use of transesophageal 
echocardiography (TEE) probes, which are used in the majority of 
all cardiac procedures.21Afewoutbreakshavebeendescribedlink-
ing TEE probes with respiratory infections after cardiac surgery, 
Enterobacter cloacae22 (17 patients) and Pseudomonas aeruginosa23 
(eight patients) in Japan and Escherichia coli24 (eight patients) in the 
UnitedStates.Acommonfactorinallthreeoutbreakswasdamage
to the probes, presumably preventing adequate decontamination.
1.1 | The outbreaks
In the year 2014, multiple patients in the intensive care unit (ICU) 
at Landspitali University Hospital developed pneumonia with an 
extensively beta-lactam resistant Klebsiella oxytoca.Afteradetailed
investigation for possible sources of contamination in the ICU en-
vironment, the same strain of K oxytoca was isolated from a TEE 
probe which had been used in most cardiac operations at the hos-
pital. Careful inspection under magnification revealed a small crack 
at the junction of the tip and the shaft of the TEE probe. The probe 
was subsequently replaced with another one that was previously un-
used but several years old. The use of a protective sheath to cover 
the probe while in patient use was encouraged, but not enforced. 
The outbreak strain of K oxytoca was not identified in any cardiac 
patient after changing the TEE probe. However, in the year 2017, 
three patients died of septic shock due to P aeruginosa shortly after 
cardiac surgery and two patients developed endocarditis due to 
Enterococcus faecalis between 1 and 12 weeks after cardiac surgery. 
One of those patients died. Inspection of the replacement TEE probe 
revealedminutedamage,seeFigure1,andbothpathogenswerecul-
tured from the probe despite decontamination.
Given the two recent outbreaks described above, the aim of our 
study was to examine the incidence of infections after cardiac sur-
gery in a nationwide population and how it related to periods with 
acontaminatedTEEprobeinuse.Additionally,wedescribetherisk
factors for infections and the general outcome of cardiac surgery 
patients in Iceland.
2  | METHODS
2.1 | Study design and setting
This was a retrospective, nationwide, observational study conducted 
at Landspitali University Hospital in Reykjavik, Iceland. Landspitali is 
a tertiary care centre serving a population of 350 000 with around 
200 open-heart surgeries performed each year. It is the sole pro-
vider of cardiac surgery in Iceland. During the study period, a sin-
gle TEE probe was located in the cardiac surgery theatre and used 
in themajority of procedures. A second probe could be obtained
if needed from the ICU (eg, in case of two concurrent operations). 
Post-operative cardiac surgery patients were admitted to a 7 bed 
multidisciplinary ICU for at least one night. Per protocol cefazolin 
was used for surgical antibiotic prophylaxis (1 g every 8 hours for 
48 hours) or clindamycin in patients allergic to beta-lactam antibiot-
ics. Microbiology cultures were only requested in cardiac surgery 
patients upon clinical suspicion of infection.
2.2 | Patient selection and data collection
Allconsecutivepatients(≥18years)whounderwentopen-heartsur-
gery at Landspitali from 1 January 2013 to 31 December 2017 were 
included. Data collected from patients´ electronic medical charts, 
hospital laboratories and the operation planning system were en-
tered into an Excel spreadsheet (Microsoft Office 2016, Version 
1810). The European System for Cardiac Operative Risk Evaluation 
(EuroScore II) scoring system was used to assess preoperative and 
surgical risk factors.25 The occurrence or absence of infection in 
each patient was judged by study authors using all available clinical 
data. Infections were defined and classified based on the definitions 
of the European Center for Disease Prevention and Control.26
Microbiology cultures were reviewed in all patients for 30 days 
after surgery, or up to 90 days for deep surgical infections and 
endocarditis. Additional outcome data collected included the
development of a new-onset atrial fibrillation, stroke, need for 
Editorial comment
This report describes an analysis of post-operative infec-
tious complications during a recent period in a single cen-
tre cardiac surgical cohort. There is specific focus on risk 
associated with reused equipment, with tracking to 
transesophageal echo probes.
F I G U R E  1   The tip of one of the transesophageal 
echocardiography probes in use during the study period. With 
magnification and specific lighting used in this photograph, 
numerous superficial scratches and a crack (arrow) in the plastic 
casing can be visualized. The damage was not obvious to the 
naked eye. The outbreak strains of Pseudomonas aeruginosa and 
Enterococcus faecalis were isolated from this crack, after the probe 
had been decontaminated and was ready for use (Photo: Thorkell 
Thorkelsson) [Colour figure can be viewed at wileyonlinelibrary.com]
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pleurocentesis, pericardiocentesis, renal replacement therapy, cir-
culatory mechanical assist devices or reoperation, length of venti-
lation, need for re-intubation, length of stay in the ICU and hospital, 
and 30-day and in-hospital mortality. Two periods with a damaged 
andcontaminatedTEEprobeinuseweredefined:Fromthedateof
surgery of the first (30 October 2013) and the last (12 November 
2014) patient with K oxytoca pneumonia and the first (15 September 
2016)andlast(12April2017)patientwithP aeruginosa pneumonia.
2.3 | End points
The main end point was the diagnosis of a new infection within 
30 days after cardiac surgery, or 90 days for deep surgical site infec-
tions and endocarditis. Secondary end points included the incidence 
of complications as described above and mortality after cardiac 
surgery.
2.4 | Statistical analysis
Statistical analysis was performed using SPSS (IBM, Build 1.0.0.1126). 
Proportions are presented as percentage with confidence intervals. 
Fornormallydistributeddata,meansandstandarddeviation(SD)are
reported. The median and interquartile range (IQR) are reported for 
non-normally distributed data. Pearson's chi-squared test was used 
for categorical variables and odds ratios (OR) are reported with 95% 
confidence intervals (CI). Mann-Whitney U test was used for com-
paringlengthofstaybetweengroups.Foranalysisofriskfactorsfor
infections and mortality, patient characteristics were entered into 
a univariate logistic regression with development of an infection or 
mortality as the dependent variable. Factors associated individu-
ally with the development of an infection (P < 0.05) were entered 
into a forward conditional multivariate logistic model. Missing val-
ues were common for preoperative pulmonary artery pressure (67% 
of subjects), preoperative left ventricular ejection fraction (11% of 
subjects) and ventilation time (17% of subjects) but otherwise miss-
ing data were <1%. When calculating the EuroScore II, missing data 
were presumed to have been normal.
3  | RESULTS
3.1 | The patient cohort
Nine hundred seventy-three patients underwent open-heart sur-
gery at Landspitali in the 5-year study period (2013-2017), with the 
annual number of operations decreasing from 224 in the first year 
to 141 in the last year of the study. Patient characteristics are pre-
sented in Table 1.
3.2 | Post‐operative infections
One hundred ninety-eight (20.3%) patients developed one or more 
infection post-operatively, see Table 2. The total number of regis-
tered infections was 273.
Pneumonia was the most common infection and was diag-
nosed in 89 patients (9.1%). The incidence rate was 13.8% (95% CI 
10.5%-17.8%) in the two periods with a damaged TEE probe in use 
and 6.6% (95%CI 5.0%-8.9%) in other periods. Amarked drop in
pneumonia incidence was observed after TEE probe changes, see 
Figure2.
Of all 89 patients with pneumonia, 67 (74.1%) were diagnosed 
while still in the ICU. The median time of diagnosis was on post-op-
erative day 3 (IQR 2-4). The majority of patients with pneumonia 
(61 [68.5%]) had positive microbiological cultures, these came from 
tracheal aspirates (42), bronchoalveolar lavage (11) and sputum (8). 
The most commonly isolated pathogens were: K oxytoca (23), P aeru-
ginosa (10), Serratia marcescens (8), E cloacae (8), Klebsiella pneumo-
niae (7) and E coli (5). Incidence rates for E cloacae, K pneumoniae 
and E coli were low throughout the study period but K oxytoca and 
P aeruginosaexhibitedpeaksinincidence,seeFigure3.
3.3 | Two outbreaks traced to damaged 
transesophageal echocardiography probes
Anextensivelybeta-lactamresistantstrainofK oxytoca was found 
in respiratory samples of 22 patients after intraoperative use of the 
first contaminated TEE probe. One patient died during the hospital 
stay but the death was not considered to be related to the infec-
tion. With the second probe, a total of 10 patients had P aeruginosa 
in respiratory samples, of which three also had a bloodstream in-
fection.Allthreepresentedwithsepticshockwithin3daysoftheir
surgery and died in hospital. One additional patient with P aerugi-
nosa pneumoniadiedbeforehospitaldischarge.Alsowiththesec-
ond probe, two patients developed endocarditis with E faecalis in 
a biologic valve prosthesis within a 3-month period, one of whom 
died.Allthreebacteria(K oxytoca, P aeruginosa and E faecalis) could 
be cultured from the TEE probe in use at the respective time (after 
decontamination).
3.4 | Risk factors for and the impact of infections
Several factors were associated with the development of a post-op-
erative infection, see Table 3.
In a multivariate model, the duration of procedure (adjusted OR 
1.006, 95% CI 1.004-1.008, P < 0.001), age (adj. OR 1.035, 95% CI 
1.015-1.054, P < 0.001), insulin-dependent diabetes (adj. OR 3.174, 
95% CI 1.665-6.052, P < 0.001), the EuroScore II (adj. OR 1.049, 95% 
CI 1.016-1.083, P = 0.03), reoperation for bleeding (adj. OR 1.939, 
95% CI 1.053-3.572, P = 0.034) and operation within a contaminated 
TEE period (adj OR 1.558, 95% CI 1.078-2.253, P = 0.018) remained 
independently associated with the development of an infection.
3.5 | Complications and outcome
Thirty-one patients died within 30 days of the index surgery (3.2%) 
and further three after that while still in hospital (in-hospital mor-
tality 3.5%). Of those who died within 30 days, the most common 
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causes of death were: Cardiovascular (13 patients), infectious (12 pa-
tients), stroke (two patients) and unknown (four patients). The most 
frequent complications were new-onset atrial fibrillation (31.6%), in-
fections(20.3%)andtheneedforpleurocentesis(10%).Apartfrom
atrial fibrillation and pericardiocentesis, all complications were as-
sociated with an increased risk of death on a univariate analysis, see 
Table 4.
The median length of stay in the ICU was 1 day (IQR 1-2) and 
in hospital was 8 days (IQR 7-12). In patients extubated within 
24 hours, extubation time was at a median of 6 hours and 32 min-
utes post-surgery (IQR 4:30-8:52). Re-admissions to the ICU were 
42 (4.3%).
Infected patients had a longer duration of stay in the ICU (median 
2 days, IQR 1-6) than patients without an infection (median 1 day, 
IQR 1-1, P < 0.001) and they also had a longer duration of stay in the 
hospital, median 14 days (IQR 9-27.8) vs 8 days (IQR 7-10, P < 0.001). 
Patients who developed a post-operative infection had a higher 
30-day mortality rate (8.1%) compared with 1.9% for non-infected 
patients (OR 4.454, 95% CI 2.162-9.176, P < 0.001). The highest 30-
day mortality rates were encountered in patients with bloodstream 
infections (19%, 95% CI 8.2-36.7) and pneumonia (17%, 95% CI 
10.5-26.0).
4  | DISCUSSION
We report epidemiological data on post-operative infections and 
outcomes from a nationwide cohort of cardiac surgery patients. 
During the study period, there were two large outbreaks of infec-
tions associated with damaged and contaminated TEE probes, which 
had a major effect on our infection rates.
The total infection rate (20.3%) at our institution is higher 
than has been reported in recent large cardiac surgery cohorts 
(13.3%7-14%9). We report a particularly high pneumonia incidence 
(13.8%) from periods with a damaged TEE probe in use but the in-
cidence in other periods (6.6%) is within the range others have re-
ported (2.4%-10.7%).3,6,9,13,14
The rates of other infections, such as surgical site infections 
(5.7%), bloodstream infections (2.8%), deep sternal infection (1.7%) 
and symptomatic urinary tract infections (1.4%) are similar to reports 
from other centres.3,8,9 Analysis of our data confirms previously
TA B L E  1   Preoperative and surgical characteristics of 973 
consecutive patients undergoing cardiac surgery in Iceland
Patient characteristics (n = 973)
Preoperative
Age(mean) 66.7 y SD 11.50
Males 76%
Weight (mean) 86.1 kg SD 15.67
Chronic lung diseasea  77 7.9%
Extracardiac arteriopathyb  58 6.0%
Insulin-dependent diabetes 
mellitus
51 5.2%
Dialysis dependent 13 1.3%
Anginapectorisatrest 134 13.8%
Recent myocardial infarctionc  178 18.3%
Critical pre-op conditiond  48 4.9%
LV Ejection fraction (mean) 53% SD 11.0
NYHAclasse 
0 94 9.7%
I 97 10.0%
II 357 36.7%
III 238 24.5%
IV 187 19.2%
Surgical
Proceduref 
CABG 483 49.6%
AVR 156 16.0%
CABG+valve 113 11.6%
Aorticsurgery 61 6.3%
MVR 29 3.0%
OPCAB 26 2.7%
Others 105 10.8%
Duration of procedure (mean) 242 min SD 90.8
Re-do procedure 25 2.6%
Activeendocarditisg  18 1.8%
Urgencyh 
Elective 511 52.5%
Urgent 386 39.7%
Emergency 68 7.0%
Salvage 8 0.8%
EuroScore II (median) 1.82 IQR 1.07-3.77
EuroScore II (mean) 3.78 SD 5.8
aLong-term use of bronchodilators or steroids for lung disease. 
bOne or more of the following: carotid occlusion or >50% stenosis, am-
putation for arterial disease, previous or planned intervention on the 
abdominal aorta, limb arteries or carotids. 
cMyocardial infarction within 90 d. 
dCritical preoperative state: Ventricular tachycardia or ventricular fibril-
lation or aborted sudden death, preoperative cardiac massage, preoper-
ative ventilation before anaesthetic room, preoperative inotropes or 
IABP,preoperativeacuterenalfailure(anuriaoroliguria<10mL/h).
eNewYorkHeartAssociationclass.
fAVR,aorticvalvereplacement;CABG,Coronaryarterybypassgrafting;
MVR,mitralvalvereplacement;OPCAB,Off-pumpcoronarybypass.
gActiveendocarditis:Patientstillonantibiotictreatmentforendocarditis
at time of surgery. 
hElective: Routine admission for operation. Urgent: Patients who have 
not been electively admitted for operation but who require intervention 
or surgery on the current admission for medical reasons. Emergency: 
Operation before the beginning of the next working day after decision to 
operate. Salvage: Patients requiring cardiopulmonary resuscitation (ex-
ternal cardiac massage) en route to the operating theatre or prior to in-
duction of anaesthesia. 
TA B L E  1   (Contiuned)
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known risk factors for the development of an infection, such as age, 
duration of procedure and insulin-dependent diabetes mellitus, but 
we are the first to report increased infection rates related to which 
TEE probe was in use at the time of surgery. This is (to the authors 
knowledge) the largest reported outbreak related to TEE use and the 
first with several fatalities.
At the height of the K oxytoca outbreak, 16.2% of all cardiac 
surgery patients had the pathogen in a respiratory tract sample 
(Figure3)and61%ofallrespiratorytractsamplesfromcardiacpa-
tients were positive for K oxytoca (microbiology cultures were only 
taken on clinical suspicion of an infection). The bacteria therefore 
seems to have been very efficient at colonising the respiratory tract 
of exposed patients. Several factors may have aided this. The TEE 
probe slides past the laryngeal inlet on insertion and is routinely left 
in place for several hours during surgery. Host defence mechanisms 
are also compromised due to numerous factors, such as general 
anesthesia, endotracheal tube, atelectasis, sedative drugs and the 
stress of a major operation. This efficiency of respiratory tract col-
onisation and subsequent development of pneumonia suggests that 
aspiration of secretions from the pharynx or oesophagus into the re-
spiratory tract during surgery and intubation may be more common 
TA B L E  2   Post-operative infections diagnosed in 973 
consecutive cardiac surgery patients in Iceland
Post‐operative infections (n = 973)
Pneumonia 89 9.1%
With positive cultures 61 6.2%
Clinical diagnosis only 28 2.9%
Surgical site infection 73 7.3%
Deep sternal 17 1.7%
Superficial (sternum or vein 
harvest site)
56 5.7%
Urinary tract infection 52 5.3%
Symptomatic 14 1.4%
Asymptomaticbacteriuria 38 3.9%
Bloodstream infection 27 2.8%
Endocarditisa  5 0.5%
Clostridium difficile enterocolitis 3 0.3%
Others 24 2.4%
aPatients who developed endocarditis post-operatively in a valve pros-
thesis. Patients with endocarditis prior to surgery not included. 
F I G U R E  2   Incidence of pneumonia 
after cardiac surgery over a 5-year period. 
Each column represents one quarter year. 
ArrowsindicatethetimeofTEEprobe
changes(November2014andApril2017)
F I G U R E  3   The figure shows the 
proportion of all cardiac surgery patients 
with specific bacteria isolated from a post-
operative respiratory sample
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than is generally appreciated. This risk may be increased when a TEE 
probe is used concurrently.
The clinical presentation of infections related to TEE use was 
in most cases an early-onset pneumonia within 3 days of surgery. 
Interestingly, no patient with K oxytoca had a bloodstream infection 
and there were no fatalities directly attributed to the K oxytoca in-
fections. The P aeruginosa seemed to be more virulent, with 3 of 10 
patients developing bloodstream infection with septic shock. P aeru-
ginosa has been associated with a higher mortality than other patho-
gens in previous studies on post-operative pneumonia.27
The K oxytoca outbreak went unnoticed for some time in our 
institution. The Department of infection control has an active sur-
veillance system for several pathogens, such as extended spectrum 
beta-lactamase (ESBL) producing strains of Enterobacteriaceae, but 
the K oxytoca did not produce ESBL even though it was multidrug 
resistant. The patient cohort was cared for post-operatively in a gen-
eral mixed ICU where the majority of physicians have short rotations 
and this may have hindered detection of the outbreak. The discovery 
of the P aeruginosaoutbreakwasquicker.AlthoughP aeruginosa is a 
relatively common pathogen in the ICU, the unusual clinical presen-
tation of septic shock in two post-operative cardiac patients within a 
short period led to an alert to infection control.
Our experience with two damaged probes over a relatively short 
time period suggests that TEE probe damage causing decontamina-
tion failure may be more common than is appreciated and that this 
damage can be difficult to detect. The use of protective sheaths on 
the TEE probe reduces the risk of cross-infection in case there is 
a decontamination failure. However, sheaths can be impractical as 
some users find they impair ultrasound views of the heart and not 
all sheaths are robust enough to maintain integrity during a lengthy 
surgery. We made informal enquiries to centres in both Europe and 
theUnitedStatesofAmericaandinmostcasesprotectivesheaths
were not used on TEE probes during cardiac surgery. In collabora-
tion with the Department of Infection Control, we have enhanced 
cleaning routines for TEE probes, which now include ultraviolet light 
decontamination and regular visual examination under magnification 
and enhanced lighting for signs of damage. The use of probe sheaths 
is now mandatory at our clinic.
TA B L E  3   Presented in the table are factors associated with the development of post-operative infection in a cohort of 973 cardiac 
surgery patients
Risk factors for developing a post‐operative infection—a univariate analysis
Variable Infected (n = 198) No infection (n = 775) Unadj. OR (95% CI) P‐value
Duration of procedure 279 min (SD 121.1) 233 min (SD 78.7) 1.005 (1.003-1.006) <0.001
Age(y) 69.8 (SD 10.48) 65.9 (SD 11.62) 1.034 (1.018-1.050) <0.001
Extracardiac arteriopathya  18 (9.1%) 40 (5.2%) 1.837 (1.029-3.281) 0.040
Critical pre-op conditiona  20 (10.1%) 28 (3.6%) 2.998 (1.651-5.444) <0.001
Insulin-dep. diabetes mellitus 20 (10.1%) 31 (4.0%) 2.697 (1.502-4.843) 0.001
NYHAclass
0 17 (8.6%) 77 (9.9%) Reference
I 13 (6.6%) 84 (10.8%) 0.701 (0.320-1.538) 0.375
II 50 (25.3%) 307 (39.6%) 0.738 (0.403-1.350) 0.324
III 57 (28.8%) 181 (23.5%) 1.426 (0.780-2.609) 0.249
IV 61 (30.8%) 126 (16.3%) 2.193 (1.194-4.027) 0.011
Anginaatrest 37 (18.7%) 97 (12.5%) 1.606 (1.060-2.435) 0.026
Ejection fraction 50.1% (SD 12.20) 54.1% (SD 10.49) 0.970 (0.956-0.984) <0.001
Pulm. art. pressureb  42 mm Hg (SD 12.7) 38 mm Hg (SD 13.4) 1.024 (1.005-1.043) 0.015
Recent MIa  48 (24.2%) 130 (16.8%) 1.588 (1.090-2.312) 0.016
Urgency of procedurea 
Elective 94 (47.4%) 417 (53.8%) Reference
Urgent 76 (38.4%) 310 (40.0%) 1.088 (0.777-1.522) 0.625
Emergency 26 (13.1%) 42 (5.4%) 2.746 (1.604-4.702) <0.001
Salvage 2 (1.0%) 6 (0.8%) 1.479 (0.294-7.441) 0.635
Euroscore II 2.9 (IQR 1.62-8.70) 1.6 (IQR 1.00-3.10) 1.096 (1.066-1.127) <0.001
Reoperation for bleeding 21 (10.6%) 43 (5.5%) 2.020 (1.169-3.490) 0.012
Contaminated TEE periodc  79 (40.1%) 249 (32.1%) 1.402 (1.016-1.935) 0.040
aSee definitions under Table 1. 
bThe pulmonary arterial pressure was excluded from the multivariate analysis due to a large number of missing values. 
cOperation in a time period where a damaged and contaminated TEE probe was in use. 
Statistically significant values in bold (P < 0.05)
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We cannot exclude that the high pneumonia rates we observed 
may have influenced the rates of other complications, such as the 
need for pleurocentesis (10%) and mechanical ventilation >48 hours 
(8.5%). Both were higher than the corresponding rates published in 
theSwedeheart2017Annualreport(6.3%and5.1%respectively).10 
The Swedeheart Annual report publishes outcome data annually
from around 6000 cardiac operations in Sweden, with patient char-
acteristics and EuroScore II (mean 3.1%-5.1%) very similar to the 
cohort described in our study (3.78%). The rates of other compli-
cations such as cerebrovascular accidents (2.3%) and renal replace-
ment therapy (1.7%) were similar to those reported in Swedeheart 
(2.0% and 3.0% respectively), as was the 30-day mortality, 3.2% vs 
1.6%-3.5% in the Swedeheart cohort.
The strength of this study is the nationwide cohort from a single 
institution over a 5-year period. Rather than relying on diagnostic 
codes, we reviewed the charts of every cardiac patient during the 
studyperiod.Alimitationistheretrospectivedesignandtheinher-
ent difficulties in diagnosing infections retrospectively. Especially 
pneumonia can be difficult to ascertain, given that critically ill car-
diac surgery patients invariably have infiltrates on their chest X-rays 
and frequently exhibit a systemic inflammatory response syndrome 
post cardiopulmonary bypass.
5  | CONCLUSIONS
Minor surface damage and subsequent contamination of TEE probes 
were responsible for a surge in pneumonia rates and bloodstream in-
fections with fatal outcomes in cardiac surgery patients in Iceland. This 
study highlights the importance of TEE probes as a potential risk factor 
for pneumonia following cardiac surgery and the necessity of adequate 
procedures for handling, inspection and decontamination of TEE probes.
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Rates of complications and risk of death after cardiac surgery
Complications n %
Unadj. OR for 30 d 
mortality (95% CI) P‐value
New-onset atrial fibrillation 307 31.6 0.888 (0.404-1.953) 0.768
Infection (any) 198 20.3 4.454 (2.162-9.176) <0.0001
Pleurocentesis 97 10.0 2.761 (1.157-6.587) 0.022
Mech. ventilation >48 h 83 8.5 13.930 (6.600-29.400) <0.0001
Reoperation for bleeding 64 6.6 2.878 (1.067-7.767) 0.037
Mechanical assist device  49 5.0 18.176 (8.271-39.941) <0.0001
Re-intubation 37 3.8 13.354 (5.640-31.617) <0.0001
Pericardiocentesis 27 2.8 1.174 (0.154-8.943) 0.877
Cerebrovascular accident 22 2.3 7.605 (2.410-23.994) <0.0001
Renal replacement therapya  17 1.7 20.313 (6.960-59.284) <0.0001
Reoperation for graft failure 6 0.6 na na
aAorta balloon pump or venoarterial extracorporeal membrane oxygenation (VA-ECMO)
post-operatively. 
bForpost-operativeacutekidneyinjury.
Statistically significant values in bold (P < 0.05)
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